Gerelateerd aan
-
-
The mythical village of Chelm is where, in the mid- to late-1800s, the Wise Fools lived. Where everyone was a fool, no one was aware of being foolish. These are their stories--unlike other stories in the Chelm genre, very short-form tales as read aloud in synagogue over many years. (But you don't have to be Jewish! All are welcome.)
-
New to DUST? Start with Season Three: CHRYSALIS, starring Corey Hawkins, Toni Collette, and more!
DUST is the premier destination for immersive science fiction audio stories.
Previous Seasons:
Season Three, CHRYSALIS: When an AI awakens after the genocide of the human race by an unknown alien species, it sets off on a path of vengeance across the known universe...and beyond.
Season Two, FLIGHT 008: Eleven of the biggest writers in science fiction, through eleven unique stories, follow one single thread: a non-stop flight from Tokyo to San Francisco that passes through a wrinkle in spacetime and lands in the year 2040.
Season One, HORIZONS: An anthology of audio stories ranging from Philip K. Dick and Ray Bradbury to the new voices of today.
Hosted on Acast. See acast.com/privacy for more information.
-
The Antigen podcast goes behind the science of vaccines. We examine basic science principles, review vaccine history, explore the many facets of their global impact (including COVID-19), and the public sentiment about vaccines around the world. In our latest season, we will dive into maternal immunization: the history, the challenges, the innovations, and the exciting developments to come.
This podcast is created by Pfizer. -
Epidemiolog Emma Frans och toxikolog Mattias รberg ger ett vetenskapligt perspektiv pรฅ hรคndelser som skakat vรคrlden och pรฅverkat hur vi ser pรฅ risker. Riskzonen รคr en podcast om faror som hotar, oro och hur vi hanterar livets ofรถrutsรคgbarhet. Emma och Mattias รคr bรฅda verksamma pรฅ Karolinska Institutet och jobbar bland annat med att bedรถma risker. Vรคlkommen in i riskzonen!
Hosted on Acast. See acast.com/privacy for more information.
-
-
-
After spending time in academia and exploring the unknown, the industry often seems too limited scientifically to those finishing a PhD. We will explore the bridge between the industry and academia to understand how basic scientific findings take shape into products and strategies. We will also follow the career paths of researchers who are in academia or outside of it, professionals that made their choice, followed it through and come to us to tell all about it.
Academia or not? And if not, what else? That is a tough nut to crack. Call us the nutcrackers. -
-
ืงืืจืก ืจืืฉืื (ืืืกืืืจืื ืขืืืืืช): ื ืกืงืืจ ืืช ืืชืืืืืื ืืืจืืืืื ืฉื ืืืืกืืืจืื ืืื ืืฉืืช ืืื ืืืคืขืชื ืฉื ืืืื ืืขื ืืืื. ืืืจืชื ื ืืืืืจ ืืกืืืื ืืื ืืช ืชืืืืื ืืืคืชื ืื ืงืืืืช ืืืคื ื ืืขืืงืจืืืช ืฉื ืืืืกืืืจืื, ืืืืงืืื ืืขืืื ืขื ืืงืฉืจืื ืืื ืืืืกืืืจืื ืืื ืืฉืืช ืืืื ืืืืืืืืื ืฉื ืืืื ืืืืขืจืืช ืืืงืืืืืืช ืืืืืืืืืช.
ืงืจืืื ืขื ืง ืืืืจืื ืืืืฉ ืขื ืชืืืืจื ืืคืจืงืื.
ืงืืจืก ืฉื ื (ืืืื ืืืืกืืืจืื ืขืืืืืช): ื ืกืงืืจ ืืช ืืชืืืืืื ืืืจืืืืื ืฉื ืืืืกืืืจืื ืืื ืืฉืืช ืืื ืืืคืขืชื ืฉื ืืืื ืืขื ืืืื. ืืืจืชื ื ืืืืืจ ืืกืืืื ืืื ืืช ืชืืืืื ืืืคืชื ืื ืงืืืืช ืืืคื ื ืืขืืงืจืืืช ืฉื ืืืืกืืืจืื, ืืืืงืืื ืืขืืื ืขื ืืงืฉืจืื ืืื ืืืืกืืืจืื ืืื ืืฉืืช ืืืื ืืืืืืืืื ืฉื ืืืื ืืืืขืจืืช ืืืงืืืืืืช ืืืืืืืืืช
ืงืจืืื ืขื ืง ืืืขืงื ืฉืื ืฉืืื ืืขืืจ ืืืขืืื ืฉื ืืงืืจืก
ืงืืฉืืจ ืืื ืืืคืืืงืฆืืืช
https://pod.link/1357568960
ืืขืื ืคืจืืื: http://bit.ly/PodcastsPages
ืืืืื ืฉืืขืืื ืฉื ืืคืืืงืืกื ืืื ื ืขืฉืชื ืืืชื ืืืืช ืืืื ืื ืฉืื ืจืืื ืืื ื ืืืฉืืืชื ืืื ื ืขืฉื ืืืื ืคืืคืืืจื. ืื ืืืฉืื ืืืื ืืขืื ืืื ืืกืืืืกืืืงืืช ืืื ืชืื ื ืืืื ื ืืฉืื ืืชืช ืืืชื.
ืคื ื ืืื ืืืืืืืจ: Twitter.com/RefaelCohe
ืื ืืืืืจื t.me/RefaelCohen
ืื ืืืืื [email protected] -
-
-
ืืคืืืงืืกื "ืืจืืืืช ืืืืืช", ืืืืช ืืืืฆืจ ืฉื ืืจืืื ืืืจืืืืช ืืืืื ืืืฉืจืื, ืืืืืจ ืจืืื ืืืฆืืื ืืช ืืืืืืื ืืืืจื ืืืืคืืืื ืืืืืืช ืฉืืืืข ืืจื ืฉื ืฆืืจ ืืฆืื ืืืคืื ืื ืืืช ืืืื. ืืคืืืงืืกื ืืชืืจืืื ืืืืืื ืืชืืืืื ืฉืื ืื: ืจืืคืืื, ืขืืืืื ืกืืฆืืืืื, ืคืืืืืืจืคืืกืืื, ืืืืื ืื, ืืืืืช, ืจืืงืืื ืืขืื ืื ืืฉืืื ืืืืื ืื, ืืืื ืขื ืื ืช ืืืขืฉืืจ ืืช ืืืืข ืฉืืื ืืืขืืงืจ ืืืจืื ืืื ืืฉืืืจ ืขื ืืืืจ ืืืงืจ ืืื – ืืืจืืืืช.
-
Under the DataScope: A six-episode podcast series from the Kraft Precision Medicine Accelerator at Harvard Business School, showcasing the most important companies—their innovations and their progress—that bring data and analytics technologies to precision medicine today. Discussions focus on the business models, technologies, and proof points of data and analytics leaders to illuminate the richness of this landscape today and its fast-paced future progress. Guests include: • John Wilbanks - Chief Commons Officer, Sage Bionetworks • David Shaywitz - Senior Partner, Takeda Ventures • Jeff Elton – CEO, Concerto Health AI • Wout Brusselaers – Founder/CEO, Deep6 • Richard Williams - Managing Director & CMO, Wuxi NextCode • Eyal Gura - Founder/CEO, Zebra Medical Vision
-
-
There are real differences in men's and women's health concerns. The life expectancy gap is decreasing between men and women, but men still deal with higher rates of cardiovascular disease, prostate and testicular cancers, fluctuating testosterone levels, and fertility issues. Women’s health issues include cancer, reproductive and sexual health issues, osteoporosis prevention and management, nutrition and sports medicine. This series focuses on new developments in the diagnosis and treatment of gender-specific health issues.
-
-
ืืืืจื ืืฉื ืื, ืืืงืืื ืืงืื ืืฉืจืื ืืืืช ืชืกืืืชืื - ืืืืืช ืจืืื. ืขื ืคืจืืฆืช ืืืืืืืืื ืืืฉืจืื, ืืืืืช ืืจืืื ืืืื ืื ืขืืื. ืืขืช, ืขื ืืชืืืื ืฉืขืืืจ ืืืืืื ืืงืืื ืืืืืช ืืืกืืชืื (ืคืืืงืืกืืื) ืื ืื ื ืืืืจืื ืืืงืืื ืืืืืช ืืขืืืืื ืืงืื. ืืื ืืกืืชืื ืืฉืืืื ืืืืืช ืขื ืชืืืจืื ืชืืื ืข ืืืืฉืืช, ืืืืืงื ืืืืื ืืื ื ืืชื ืื ืื ืืืคืฆื ืฉื ืืฆืืจื ืืฉืจืืืืช ืืงืืจืืช.
ืชืกืืืชื "ืืืื ืืืช" ืืืคืงื ืืืกืืช ืคืกืืืื ืชืืื ืข 2020
-
The data struggle is real. Companies are awash in data that can lead to better engineered products, improved customer engagement, and faster drug development. But first they have to overcome the daunting technical and cultural challenges of mastering it. Fortunately, other data and IT leaders have dealt with these same issues. They’ll share their advice and stories on the DataMasters podcast.